Table 1 IC30 and IC50 of five anti-cancer agents against YBC-2, YBC-3, NCI-N87, U-87 MG and SK-BR-3 cell lines

82.36

11.83

1326.72

0.02

289.09

0.6

0.76

0.01

0.03

0.07

1.79

21

9.28

14.54

2.58

0.52

6.45

0.86

0.19

0.3

33.11

0.22

4.11

148.75

5.51

Cell lines (IC ₅₀ ) μM

YBC-2

YBC-3

NCI-N87

SK-BR-3

U-87 MG

2.93

2.31

0.07

0.1

0.29

4.51

30.73

45.86

5.65

20.63

1.24

9.61

1.49

0.42

0.79

752.04

4.74

119.61

753.42

46.58